Noile-Immune
4893.TNoile-Immune Biotech Inc. Price (4893.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
43,297,530
(4.4113)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Noile-Immune Biotech Inc.Currency: JPY
| YEAR | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
97,277,000.00
+0% |
100,732,000.00
+4% |
625,783,000.00
+521% |
316,818,000.00
-49% |
7,000,000.00
-98% |
||||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 2,970,000.00 | 22,899,000.00 | 7,077,000.00 | 2,257,000.00 | 0.00 | ||||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
94,307,000.00
+0% |
77,833,000.00
-17% |
618,706,000.00
+695% |
314,561,000.00
-49% |
7,000,000.00
-98% |
||||||||||||||
| Gross Profit Ratio | (0.97%) | (0.77%) | (0.99%) | (0.99%) | (1.00%) | ||||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 413,060,000.00 | 514,827,000.00 | 334,804,000.00 | 646,705,000.00 | 579,000,000.00 | ||||||||||||||
| General and Administrative | 285,723,000.00 | 330,517,000.00 | 390,247,000.00 | 443,247,000.00 | 0.00 | ||||||||||||||
| Selling, General & Admin... | 285,723,000.00 | 330,517,000.00 | 390,247,000.00 | 443,247,000.00 | 497,000,000.00 | ||||||||||||||
| Selling & Marketing Exp... | 2,970,000.00 | 22,899,000.00 | 7,077,000.00 | 0.00 | 0.00 | ||||||||||||||
| Depreciation and Amortiz... | 12,806,000.00 | 766,000,000.00 | 106,000,000.00 | 0.00 | 1,069,000,000.00 | ||||||||||||||
| Other Expenses | -3,531,000.00 | -25,183,000.00 | -283,390,000.00 | 0.00 | 0.00 | ||||||||||||||
| Total Operating Expenses | 698,783,000.00 | 845,344,000.00 | 725,051,000.00 | 1,089,952,000.00 | 1,076,000,000.00 | ||||||||||||||
| Cost and Exponses | 701,753,000.00 | 868,243,000.00 | 732,128,000.00 | 1,092,209,000.00 | 1,076,000,000.00 | ||||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-604,477,000.00
+0% |
-767,511,000.00
+27% |
-106,345,000.00
-86% |
-775,391,000.00
+629% |
-1,069,000,000.00
+38% |
||||||||||||||
| Operating Income Ratio | (-6.21%) | (-7.62%) | (-0.17%) | (-2.45%) | (-152.71%) | ||||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 3,883,000.00 | 80,000.00 | 55,000.00 | 44,000.00 | 0.00 | ||||||||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Total Other Income/Exp... | -26,495,000.00 | -25,104,000.00 | -277,857,000.00 | -352,203,000.00 | 107,000,000.00 | ||||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -591,670,000.00 | 0.00 | 0.00 | -775,391,000.00 | 0.00 | ||||||||||||||
| EBITDA ratio | (-5.81%) | (-7.62%) | (-0.17%) | (-2.45%) | (0.00%) | ||||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -630,972,000.00 | -792,615,000.00 | -384,202,000.00 | -1,127,594,000.00 | -962,000,000.00 | ||||||||||||||
| Income Before Tax Ratio | (-6.49%) | (-7.87%) | (-0.61%) | (-3.56%) | (-137.43%) | ||||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 5,676,000.00 | 2,420,000.00 | 2,420,000.00 | 2,420,000.00 | 2,000,000.00 | ||||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -636,649,000.00
+0% |
-795,035,000.00
+25% |
-386,622,000.00
-51% |
-1,130,014,000.00
+192% |
-964,000,000.00
-15% |
||||||||||||||
| Net Income Ratio | (-6.54%) | (-7.89%) | (-0.62%) | (-3.57%) | (-137.71%) | ||||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -15.48 | -19.33 | -9.87 | -27.25 | -22.26 | ||||||||||||||
| Diluted EPS | -14.52 | -19.33 | -9.87 | -27.25 | -22.26 | ||||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 41,119,665.00 | 41,119,665.00 | 39,168,000.00 | 41,468,224.00 | 43,297,530.00 | ||||||||||||||
| Diluted Share Outstanding | 43,855,065.00 | 41,119,665.00 | 39,168,000.00 | 41,468,224.00 | 43,297,530.00 | ||||||||||||||